Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current Assets
Cash	$ 11,524,846	$ 3,958,957
Accounts receivable, net	2,936,999	2,834,750
Product deposit	246,279	127,265
Inventory, net	3,382,582	3,703,363
Other current assets	1,074,063	687,022
Total Current Assets	19,164,769	11,311,357
Non-current Assets
Equipment, net	462,446	476,441
Right of use asset	1,114,791	1,206,009
Capitalized software, net	9,529,525	8,840,187
Intangible assets, net	3,598,299	3,831,859
Total Non-current Assets	14,705,061	14,354,496
Total Assets	33,869,830	25,665,853
Current Liabilities
Accounts payable	6,903,034	10,106,793
Accrued expenses	11,575,597	12,166,509
Notes payable, net	1,822,489	2,797,250
Current operating lease liabilities	821,941	756,093
Deferred revenue	5,895,545	5,547,506
Total Current Liabilities	27,018,606	31,374,151
Long-term Liabilities
Convertible long-term debt, net	13,423,121
Noncurrent operating lease liabilities	407,857	574,136
Contingent consideration	381,250	443,750
Purchase price payable		579,319
Total Liabilities	41,230,834	32,971,356
Commitments and Contingencies (Note 10)
Mezzanine Equity
Preferred Stock, $0.0001 par value; 5,000,000 shares authorized Series B Preferred Stock, $0.0001 par value; 5,000 shares authorized, 3,500 and 3,500 shares issued and outstanding, liquidation value approximately, $1,337 and $1,305 per share as of March 31, 2023 and December 31, 2022, respectively	4,678,014	4,565,822
Stockholders’ Deficit
Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, $28.39 and $27.84 per share as of March 31, 2023 and December 31, 2022, respectively	140	140
Common stock, $0.01 par value; 100,000,000 shares authorized, 32,040,045 and 31,552,775 shares issued, 31,937,005 and 31,449,735 outstanding as of March 31, 2023 and December 31, 2022, respectively	320,401	315,528
Additional paid-in capital	183,183,652	179,015,250
Accumulated deficit	(195,348,013)	(190,562,994)
Treasury stock, 103,040 and 103,040 shares, at cost, as of March 31, 2023 and December 31, 2022, respectively	(163,701)	(163,701)
Total LifeMD, Inc. Stockholders’ Deficit	(12,007,521)	(11,395,777)
Non-controlling interest	(31,497)	(475,548)
Total Stockholders’ Deficit	(12,039,018)	(11,871,325)
Total Liabilities, Mezzanine Equity and Stockholders’ Deficit	$ 33,869,830	$ 25,665,853